Abstract:
The present invention is directed at aqueous suspensions of oxime compounds, such as 2-pyridine aldoxime methyl chloride (2-PAM Cl) for autoinjectors. The suspensions are able to provide 600 mg of 2-PAM Cl in one relatively small dose of less than or equal to 1.0 mL, and are particularly useful for placement in relatively small size autoinjectors.
Patent Number:
10,350,200
Date Of Issue:
07/16/2019
Inventors:
Hong Dixon; Joseph A. McDonough; Larry A. Campbell
Full Text: